Allergies News and Research

Latest Allergies News and Research

New data on personalized approaches for skin, ovarian and lung cancer to be presented at ASCO meeting

Genentech, a member of the Roche Group, today announced that data showing new personalized approaches for people with skin and lung cancer, plus new data with Avastin in ovarian cancer, will be presented at the 47th Annual Meeting of the American Society of Clinical Oncology.

18 May 2011

Impaired ability to handle oxidative stress may contribute to asthma development

An impaired ability to handle oxidative stress that arises from exposure to secondhand smoke and other environmental triggers may contribute to the development of asthma, according to results obtained from the Shanghai Women's Health Asthma and Allergy Study. The results of the study suggest regulating the body's antioxidant defense system may play an important role in asthma prevention.

18 May 2011

New bronchial thermoplasty long-term safety data in asthma presented at ATS annual meeting

Boston Scientific Corporation today announced long-term safety data from the Research in Severe Asthma (RISA) Trial, which demonstrated the maintenance of stable lung function and the absence of clinical complications over a five-year period in patients with severe refractory asthma treated with its Alair Bronchial Thermoplasty System.

17 May 2011

Concern over vaccine safety prevents parents from vaccinating asthmatic children

Concern over vaccine safety is one of the primary factors preventing parents from having their asthmatic children vaccinated for influenza, or flu, according to Michigan researchers. Parents who do not vaccinate their children are also less likely to view flu as a"trigger" for their child's asthma, the researchers noted.

17 May 2011

Study: HIV treatment drugs slash transmission risk

AIDS researchers offered evidence backing up the long-standing idea that people infected with HIV who are being treated are much less likely to transmit the virus than those who are not on drugs. This finding is being hailed as a breakthrough.

16 May 2011

Early HIV treatment can reduce transmission risk by 96%, preliminary study results show

Preliminary results from a multicountry clinical trial, sponsored by the National Institute for Allergy and Infectious Diseases (NIAID), show that HIV-positive people who take combination antiretroviral therapy (ART) can reduce the risk of transmitting the virus to their HIV-negative partners by 96 percent, U.S. researchers announced on Thursday " in what is being hailed as a breakthrough in HIV prevention," the Los Angeles Times reports.

16 May 2011

The Lancet publishes two pirfenidone Phase 3 trial results in idiopathic pulmonary fibrosis

InterMune, Inc. today announced the publication of results from two Phase 3 trials demonstrating that treatment with pirfenidone, a novel antifibrotic and anti-inflammatory drug, was associated with favorable effects on lung function, 6-minute walk test distance and progression-free survival (PFS) in patients with mild to moderate idiopathic pulmonary fibrosis (IPF).

16 May 2011

AIDS spread prevention by vaccine and anti HIV drugs

A latest vaccine against HIV/AIDS has shown to be effective in monkeys and has protected macaques the most widespread primate genus, against the monkey equivalent of HIV, Simian immunodeficiency virus (SIV). This could provide a fresh approach to an HIV vaccine, a study suggests. US researchers say the vaccine offered protection to 13 of 24 Rhesus macaques treated in the experiment. In 12 of the monkeys, the vaccine was still effective 12 months later.

15 May 2011

Cockroaches are a leading trigger of allergies and asthma attacks

May marks National Allergy and Asthma Awareness Month, and the National Pest Management Association warns families that cockroaches are a leading trigger of allergies and asthma attacks. The pests' saliva, droppings and decomposing bodies contain allergen proteins known to trigger allergies and increase the severity of asthma symptoms, especially in children.

13 May 2011

Simple tips for avoiding allergies and asthma during summer

Summertime means outdoor fun at weddings, graduations, festivals and picnics. But uninvited guests ranging from stinging insects to grass pollen can ruin the fun for the millions of Americans with allergies and asthma.

13 May 2011

Children can benefit from The Asthma Management Plans in School Act

New legislation introduced by Rep. Mazie Hirono (D-HI) would provide grants for asthma management programs in schools across the U.S. in a step to ensure the nation's 7.1 million children with asthma have access to care that could save their lives.

12 May 2011

New genome-wide study identifies causes of serious childhood immune disorder

A new genomics study, led by the Center for Applied Genomics at The Children's Hospital of Philadelphia, sets the stage for the first predictive diagnostic test in a serious immunodeficiency disease in children. If the disorder, common variable immunodeficiency disease, can be diagnosed early, children may receive life-saving treatments before the disease can progress.

12 May 2011

Liquid rice hull smoke could help fight diseases

Liquid smoke flavoring made from hickory and other wood - a mainstay flavoring and anti-bacterial agent for the prepared food industry and home kitchens - may get a competitor that seems to be packed with antioxidant, antiallergenic and anti-inflammatory substances, according to a new study in ACS' Journal of Agricultural and Food Chemistry. It is the first analysis of liquid smoke produced from rice hulls, the hard, inedible coverings of rice grains.

12 May 2011

Inovio first quarter total revenue increases to $3.1 million for 2011

Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2011.

11 May 2011

Safety tips for athletes with asthma and allergies

As athletes of all ages take the field this summer, the most fearsome opponents for those with asthma and allergies might be triggers that can sideline even the toughest competitors.

11 May 2011

Plexxikon seeks vemurafenib marketing approval from FDA and EMA for melanoma treatment

Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced that applications for market approval for vemurafenib for the treatment of metastatic melanoma have been submitted to the U.S. Food and Drug Administration and the European Medicines Agency.

11 May 2011

KFA announces plans for charity Game-A-Thon and food allergy campaign

Kids With Food Allergies Foundation today announced plans for a charity Game-A-Thon and the Faces of Food Allergies Campaign in honor of National Asthma and Allergy Awareness Month, which includes Food Allergy Awareness Week from May 8-14.

7 May 2011

Study finds 4.5 million outpatient visits yearly due to adverse drug effects

Harmful effects of medication bring an estimated 4.5 million patients to doctors' offices and emergency rooms yearly, according to a new study, and people who take multiple medications are particularly vulnerable to unpleasant or dangerous side effects, allergic reactions and toxicity.

7 May 2011

NYU, LaSalle University develop new effective asthma-related anxiety tool

When children or adolescents with asthma and their parents become overly anxious about the disorder, it may impair their ability to manage the asthma effectively. A new, effective tool to assess asthma-related anxiety is described in an article in Pediatric Allergy, Immunology, and Pulmonology, a peer-reviewed journal published by Mary Ann Liebert, Inc.

6 May 2011

Neutralizing antibodies generated by immunization associated with protection against SIV infection

Using a monkey model of AIDS, scientists have identified a vaccine-generated immune-system response that correlates with protection against infection by the monkey version of HIV, called simian immunodeficiency virus (SIV). The researchers found that neutralizing antibodies generated by immunization were associated with protection against SIV infection.

6 May 2011

Allergies News and Research

Latest Allergies News and Research

New data on personalized approaches for skin, ovarian and lung cancer to be presented at ASCO meeting

Impaired ability to handle oxidative stress may contribute to asthma development

New bronchial thermoplasty long-term safety data in asthma presented at ATS annual meeting

Concern over vaccine safety prevents parents from vaccinating asthmatic children

Study: HIV treatment drugs slash transmission risk

Early HIV treatment can reduce transmission risk by 96%, preliminary study results show

The Lancet publishes two pirfenidone Phase 3 trial results in idiopathic pulmonary fibrosis

AIDS spread prevention by vaccine and anti HIV drugs

Cockroaches are a leading trigger of allergies and asthma attacks

Simple tips for avoiding allergies and asthma during summer

Children can benefit from The Asthma Management Plans in School Act

New genome-wide study identifies causes of serious childhood immune disorder

Liquid rice hull smoke could help fight diseases

Inovio first quarter total revenue increases to $3.1 million for 2011

Safety tips for athletes with asthma and allergies

Plexxikon seeks vemurafenib marketing approval from FDA and EMA for melanoma treatment

KFA announces plans for charity Game-A-Thon and food allergy campaign

Study finds 4.5 million outpatient visits yearly due to adverse drug effects

NYU, LaSalle University develop new effective asthma-related anxiety tool

Neutralizing antibodies generated by immunization associated with protection against SIV infection

Forensics and toxicology - Industry Focus eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Allergies News and Research

Latest Allergies News and Research

Forensics and toxicology - Industry Focus eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in